SCHEMBL21159018

SCHEMBL21159018

CN1CCC2(CC1)CN2C(=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.46
LMNA P02545 1/20 0.45
MAPK1 P28482 2/20 0.44
GRM5 P41594 1/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 2/20 0.43
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HPGD P15428 3/20 0.42
CHRM1 P11229 1/20 0.42
ACHE P22303 1/20 0.41
SLC22A1 O15245 1/20 0.41
SLC6A4 P31645 1/20 0.41
ADRA1A P35348 1/20 0.41
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
KCNH2 Q12809 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20153274 0.84 LMNA (0.50) POLBLMNAMAPK1ALDH1A1MAPT
SCHEMBL20070899 0.83 CYP2D6 (0.47) POLBMAPK1ALDH1A1KMT2AHPGD
SCHEMBL20160528 0.83 OPRM1 (0.48) MAPK1KDM4ECHRM1OPRM1OPRD1
SCHEMBL20153277 0.82 CYP3A4 (0.56) POLBMAPK1ALDH1A1MAPTKMT2A
SCHEMBL18389857 0.77 CYP3A4 (0.58) POLBMAPK1GRM5ALDH1A1HPGD
SCHEMBL20153163 0.74 GPR183 (0.53) KCNH2
SCHEMBL26814639 0.74 POLB (0.42) POLBMAPK1ALDH1A1KMT2AKDM4E
SCHEMBL4107014 0.73 MAPK1 (0.57) LMNAMAPK1ALDH1A1KMT2AHPGD
SCHEMBL4143496 0.72 POLB (0.80) POLBGRM5ALDH1A1KMT2AL3MBTL1
SCHEMBL28285871 0.72 MAPK1 (0.56) LMNAMAPK1ALDH1A1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10555944-B2 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors ELI LILLY AND COMPANY (US) 2020-02-11 US disclosed
US-20190183886-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. 2019-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10555944-B2 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors RET, ROR1, BRAF POLB 3678/4885LMNA 2631/4885MAPK1 87/4885
US-20190183886-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, ROR1, BRAF POLB 3678/4885LMNA 2631/4885MAPK1 87/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.